# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-22-016722
Filing Date
2022-04-29
Accepted
2022-04-29 06:06:48
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | ny20003245x2_defa14a.htm | DEFA14A | 10453
2 |  | ny20003245x2_nc01.jpg | GRAPHIC | 758319
3 |  | ny20003245x2_nc02.jpg | GRAPHIC | 530890
| Complete submission text file | 0001140361-22-016722.txt |  | 1787358

Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39303 | Film No.: 22869843
SIC: 2834 Pharmaceutical Preparations